Helsinn Therapeutics (U.S.), Inc., a subsidiary of Helsinn Healthcare SA, is a prominent player in the biopharmaceutical industry, headquartered in the United States. Founded in 1977, the company has established itself as a leader in the development of innovative therapies for cancer and other serious medical conditions, with a strong focus on supportive care. With operational regions spanning North America and beyond, Helsinn is renowned for its unique portfolio of products, including anti-emetics and treatments aimed at improving the quality of life for patients undergoing cancer therapies. The company’s commitment to research and development has led to significant milestones, including the successful launch of several key products that address unmet medical needs. Helsinn Therapeutics is recognised for its strategic partnerships and robust market position, making it a trusted name in the healthcare sector, dedicated to enhancing patient outcomes through science-driven solutions.
We don't have data for Helsinn Therapeutics (U.S.), Inc., but we can show you information about their parent organization instead.
View parent company